cefuroxime axetil + clavulanic acid

Cefscot is a combination antibiotic medication consisting of cefuroxime axetil and potassium clavulanate. Cefuroxime axetil is a second-generation cephalosporin that exerts its bactericidal effect by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs). Potassium clavulanate is a beta-lactamase inhibitor that prevents the degradation of cefuroxime by beta-lactamase-producing bacteria, thereby extending its spectrum of activity. This combination is typically used for the treatment of respiratory tract infections, urinary tract infections, and skin and soft tissue infections caused by susceptible organisms. It is marketed as a branded generic by Pharma Drugs & Chemicals, often under a PCD (Propaganda Cum Distribution) franchise model.

Brand names

Cefscot

Other names

Cefscot-500 CVCefscot500 CVCefscot 500 CV